RGC Key Statistics, Chart & Performance
The current stock price of RGC is 26.68 USD. In the past month the price decreased by -39.51%. In the past year, price increased by 26935.7%.
RGC Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 100% of all stocks.
RGC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RGC. While RGC has a great health rating, there are worries on its profitability.
RGC Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -54.68% | ||
| ROE | -60.86% | ||
| Debt/Equity | 0 |
RGC Forecast & Estimates
RGC Ownership
RGC Latest News, Press Relases and Analysis
RGC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.54 | 987.61B | ||
| JNJ | JOHNSON & JOHNSON | 20.46 | 574.955B | ||
| MRK | MERCK & CO. INC. | 21.65 | 292.01B | ||
| PFE | PFIZER INC | 9.19 | 153.798B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10 | 123.713B | ||
| ZTS | ZOETIS INC | 18.66 | 56.1B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.52 | 25.427B | ||
| VTRS | VIATRIS INC | 6.31 | 17.921B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.5 | 12.337B | ||
| AXSM | AXSOME THERAPEUTICS INC | 225.04 | 9.236B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RGC
Company Profile
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Company Info
REGENCELL BIOSCIENCE HOLDING
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Hong Kong 37918 HK
CEO: Yat-Gai Au
Employees: 12
Phone: 85221550823
REGENCELL BIOSCIENCE HOLDING / RGC FAQ
What does RGC do?
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
What is the current price of RGC stock?
The current stock price of RGC is 26.68 USD. The price decreased by -3.73% in the last trading session.
Does RGC stock pay dividends?
RGC does not pay a dividend.
What is the ChartMill rating of REGENCELL BIOSCIENCE HOLDING stock?
RGC has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists RGC stock?
RGC stock is listed on the Nasdaq exchange.
Can you provide the sector and industry classification for REGENCELL BIOSCIENCE HOLDING?
REGENCELL BIOSCIENCE HOLDING (RGC) operates in the Health Care sector and the Pharmaceuticals industry.